CFDB - Cystic Fibrosis DataBase

  1. Home
  2. Database
Search (?)
at least one term
all terms
Advanced search
primary studies published, non RCT

Effects of tezacaftor/ivacaftor (TEZ/IVA) treatment in patients with cystic fibrosis and F508del/F508del-CFTR: patient-reported outcomes in a Phase 3, randomised, controlled trial (EVOLVE)

  • Year: 2019
  • Date: 1975
  • Author: Sommerburg O
Source

Pneumologie (Stuttgart, Germany), 2019, 73(SUPPPL. 1)

Participants

15 CF patients

Interventions

A complete dietary supplement consisting of a beef serum hydrolysate, a glucose polymer, and medium-chain triglycerides was given for a year.

Outcome measures

weight, clinical score, serum albumin level, WBC count

Main results

Patients who received the diet showed significant gains in weight, significant increase in clinical score, significant increase in serum albumin level, and a significant drop in the WBC count compared to control patients who did not receive the supplement.

Related topics

A, E, K vitamins supplementation

Antioxidants in cystic fibrosis

Calorie supplements in cystic fibrosis

Omega-3 fatty acids, zinc and probiotics supplements in cystic fibrosis

Pancreatic enzyme replacement therapy in cystic fibrosis

Vitamin D supplementation

Keywords: Adolescent; Amino Acids; Carbohydrates; Child; Infant; non pharmacological intervention - diet; Protein Hydrolysates; Proteins; Supplementation;